A growing body of real-world data shows efficacy of injectable treatments for pseudophakic cystoid macular edema, but evidence from well-designed large studies is lacking, according to a systematic literature review.
As noted by the authors, treatment of pseudophakic cystoid macular edema (PCME) is controversial, and there are no standardized guidelines. Topical NSAIDs are usually administered as first-line treatment, alone or in combination with topical corticosteroids. However, some patients do not respond well to the therapy and experience chronic or recurrent edema. Injectable treatments,